This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
An 18-Month Comparison of Clinical Outcomes Between Continuous-Flow Left Ventricular Assist Devices
The authors analyzed the outcomes of the continuous-flow left ventricular assist devices. The study includes 105 patients supported with HM2 (N=54), HM3 (N=25), and HW (N-26). Eighteen-month data suggested that HM3 had a better prognostic and adverse-event profile over other devices.